VWWMG
TRAW icon

Vermillion & White Wealth Management Group’s Traws Pharma TRAW Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-96
Closed -$178 – 636
2025
Q3 		$178 Hold
96
– – ﹤0.01% 557
2025
Q2 		$142 Hold
96
– – ﹤0.01% 526
2025
Q1 		$221 Sell
96
-109
-53% -$567 ﹤0.01% 507
2024
Q4 		$1.82K Hold
205
– – ﹤0.01% 322
2024
Q3 		$1.21K Hold
205
– – ﹤0.01% 309
2024
Q2 		$2.29K Hold
205
– – ﹤0.01% 300
2024
Q1 		$5.18K Hold
205
– – ﹤0.01% 247
2023
Q4 		$3.83K Buy
+205
New +$3.49K ﹤0.01% 225

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vermillion & White Wealth Management Group's TRAW Position: Q4 2025 in Review

Vermillion & White Wealth Management Group sold out of Traws Pharma (TRAW) in Q4 2025, closing a stake of 96 shares — an estimated $178 sold.

Vermillion & White Wealth Management Group first reported a position in TRAW in Q4 2023 and held it in 8 quarters. The position peaked at $5.18K in Q1 2024. 22 funds tracked by Wall St. Rank hold TRAW as of Q4 2025.

  • Vermillion & White Wealth Management Group reported no remaining Traws Pharma position as of Q4 2025 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 96 Traws Pharma shares in Q4 2025, an estimated $178.
  • Vermillion & White Wealth Management Group first reported a position in Traws Pharma in Q4 2023 and held it in 8 quarters.
  • Vermillion & White Wealth Management Group's Traws Pharma position peaked at $5.18K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2025, filed 18 Feb 2026.